Leap Therapeutics, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
LPTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
47 Thorndike Street, Suite B1 1, Cambridge, MA

There are no Buy or Sell transactions made by insiders since 11/30/2024

Leap Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BeiGene, Ltd. 10%+ Owner $20.9M Sep 24, 2021
Gilead Sciences, Inc. 10%+ Owner $15.2M Apr 10, 2024
Winklevoss Capital Fund, LLC 10%+ Owner $11M Oct 8, 2025
Perceptive Advisors Llc 10%+ Owner $10M Sep 24, 2021
William Patrick McEvoy III Chief Investment Officer, Director, 10%+ Owner $3.81M Nov 11, 2025
Augustine Lawlor Chief Operating Officer $221K Jun 30, 2025
Cynthia Sirard Chief Medical Officer $77.6K Mar 28, 2025
Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.&Sec., Director $49.8K Nov 17, 2025
Christopher Mirabelli Director $10.6K Nov 17, 2025
John Mark O'Mahony Chief Manufacturing Officer $8.71K Jun 30, 2025
Jason Baum Chief Scientific Officer $5.03K Jun 30, 2025
Christine Granfield VP, Head of Reg Affairs/Qual $5.03K Mar 28, 2025
Cavanaugh James H Director $97.00 Nov 17, 2025
Joseph Loscalzo Director Nov 11, 2025
Nissim Mashiach Director Nov 11, 2025
William Li Director Nov 11, 2025
Thomas John Dietz Director Nov 11, 2025
Patricia A. Martin Director Nov 11, 2025
Christian M. Richard Director Nov 11, 2025
Khing Djien Oei Director Nov 11, 2025
Richard Schilsky Director Nov 11, 2025
Monica Bertagnolli Director Jan 31, 2022

Recent Insider Transactions by Companies or Individuals for Leap Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.